175 related articles for article (PubMed ID: 32142732)
21. Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the
Alsuraih M; O'Hara SP; Woodrum JE; Pirius NE; LaRusso NF
JHEP Rep; 2021 Jun; 3(3):100250. PubMed ID: 33870156
[TBL] [Abstract][Full Text] [Related]
22. Histamine stimulates the proliferation of small and large cholangiocytes by activation of both IP3/Ca2+ and cAMP-dependent signaling mechanisms.
Francis HL; Demorrow S; Franchitto A; Venter JK; Mancinelli RA; White MA; Meng F; Ueno Y; Carpino G; Renzi A; Baker KK; Shine HE; Francis TC; Gaudio E; Alpini GD; Onori P
Lab Invest; 2012 Feb; 92(2):282-94. PubMed ID: 22064319
[TBL] [Abstract][Full Text] [Related]
23. The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice.
Wu N; Meng F; Invernizzi P; Bernuzzi F; Venter J; Standeford H; Onori P; Marzioni M; Alvaro D; Franchitto A; Gaudio E; Glaser S; Alpini G
Hepatology; 2016 Sep; 64(3):865-79. PubMed ID: 27115285
[TBL] [Abstract][Full Text] [Related]
24. Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.
Wu N; Meng F; Zhou T; Han Y; Kennedy L; Venter J; Francis H; DeMorrow S; Onori P; Invernizzi P; Bernuzzi F; Mancinelli R; Gaudio E; Franchitto A; Glaser S; Alpini G
FASEB J; 2017 Oct; 31(10):4305-4324. PubMed ID: 28634212
[TBL] [Abstract][Full Text] [Related]
25. FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2
O'Brien A; Zhou T; White T; Medford A; Chen L; Kyritsi K; Wu N; Childs J; Stiles D; Ceci L; Chakraborty S; Ekser B; Baiocchi L; Carpino G; Gaudio E; Wu C; Kennedy L; Francis H; Alpini G; Glaser S
Hepatol Commun; 2022 Jul; 6(7):1574-1588. PubMed ID: 35271760
[TBL] [Abstract][Full Text] [Related]
26. Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation.
Baghdasaryan A; Claudel T; Kosters A; Gumhold J; Silbert D; Thüringer A; Leski K; Fickert P; Karpen SJ; Trauner M
Gut; 2010 Apr; 59(4):521-30. PubMed ID: 20332524
[TBL] [Abstract][Full Text] [Related]
27. β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis.
Strack I; Schulte S; Varnholt H; Schievenbusch S; Töx U; Wendland K; Steffen HM; Drebber U; Dienes HP; Odenthal M
Lab Invest; 2011 Feb; 91(2):252-61. PubMed ID: 20921947
[TBL] [Abstract][Full Text] [Related]
28. Knockout of histidine decarboxylase decreases bile duct ligation-induced biliary hyperplasia via downregulation of the histidine decarboxylase/VEGF axis through PKA-ERK1/2 signaling.
Graf A; Meng F; Hargrove L; Kennedy L; Han Y; Francis T; Hodges K; Ueno Y; Nguyen Q; Greene JF; Francis H
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G813-23. PubMed ID: 25169977
[TBL] [Abstract][Full Text] [Related]
29. Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
Wan Y; Meng F; Wu N; Zhou T; Venter J; Francis H; Kennedy L; Glaser T; Bernuzzi F; Invernizzi P; Glaser S; Huang Q; Alpini G
Hepatology; 2017 Aug; 66(2):528-541. PubMed ID: 28256736
[TBL] [Abstract][Full Text] [Related]
30. TGF-β2 silencing to target biliary-derived liver diseases.
Dropmann A; Dooley S; Dewidar B; Hammad S; Dediulia T; Werle J; Hartwig V; Ghafoory S; Woelfl S; Korhonen H; Janicot M; Wosikowski K; Itzel T; Teufel A; Schuppan D; Stojanovic A; Cerwenka A; Nittka S; Piiper A; Gaiser T; Beraza N; Milkiewicz M; Milkiewicz P; Brain JG; Jones DEJ; Weiss TS; Zanger UM; Ebert M; Meindl-Beinker NM
Gut; 2020 Sep; 69(9):1677-1690. PubMed ID: 31992593
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of mast cell-derived histamine secretion by cromolyn sodium treatment decreases biliary hyperplasia in cholestatic rodents.
Kennedy LL; Hargrove LA; Graf AB; Francis TC; Hodges KM; Nguyen QP; Ueno Y; Greene JF; Meng F; Huynh VD; Francis HL
Lab Invest; 2014 Dec; 94(12):1406-18. PubMed ID: 25365204
[TBL] [Abstract][Full Text] [Related]
32. BCL3 Reduces the Sterile Inflammatory Response in Pancreatic and Biliary Tissues.
Song L; Wörmann S; Ai J; Neuhöfer P; Lesina M; Diakopoulos KN; Ruess D; Treiber M; Witt H; Bassermann F; Halangk W; Steiner JM; Esposito I; Rosendahl J; Schmid RM; Riemann M; Algül H
Gastroenterology; 2016 Feb; 150(2):499-512.e20. PubMed ID: 26526716
[TBL] [Abstract][Full Text] [Related]
33. Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase-A/5-Hydroxytryptamine/5-Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis.
Kyritsi K; Chen L; O'Brien A; Francis H; Hein TW; Venter J; Wu N; Ceci L; Zhou T; Zawieja D; Gashev AA; Meng F; Invernizzi P; Fabris L; Wu C; Skill NJ; Saxena R; Liangpunsakul S; Alpini G; Glaser SS
Hepatology; 2020 Mar; 71(3):990-1008. PubMed ID: 31344280
[TBL] [Abstract][Full Text] [Related]
34. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.
Tedesco D; Thapa M; Chin CY; Ge Y; Gong M; Li J; Gumber S; Speck P; Elrod EJ; Burd EM; Kitchens WH; Magliocca JF; Adams AB; Weiss DS; Mohamadzadeh M; Grakoui A
Gastroenterology; 2018 Jun; 154(8):2178-2193. PubMed ID: 29454797
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis.
Tsuneyama K; Kono N; Yamashiro M; Kouda W; Sabit A; Sasaki M; Nakanuma Y
J Pathol; 1999 Dec; 189(4):609-14. PubMed ID: 10629565
[TBL] [Abstract][Full Text] [Related]
36. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
[TBL] [Abstract][Full Text] [Related]
37. Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2
Moncsek A; Al-Suraih MS; Trussoni CE; O'Hara SP; Splinter PL; Zuber C; Patsenker E; Valli PV; Fingas CD; Weber A; Zhu Y; Tchkonia T; Kirkland JL; Gores GJ; Müllhaupt B; LaRusso NF; Mertens JC
Hepatology; 2018 Jan; 67(1):247-259. PubMed ID: 28802066
[TBL] [Abstract][Full Text] [Related]
38. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
Chung BK; Karlsen TH; Folseraas T
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
[TBL] [Abstract][Full Text] [Related]
39. Amelioration of Ductular Reaction by Stem Cell Derived Extracellular Vesicles in MDR2 Knockout Mice via Lethal-7 microRNA.
McDaniel K; Wu N; Zhou T; Huang L; Sato K; Venter J; Ceci L; Chen D; Ramos-Lorenzo S; Invernizzi P; Bernuzzi F; Wu C; Francis H; Glaser S; Alpini G; Meng F
Hepatology; 2019 Jun; 69(6):2562-2578. PubMed ID: 30723922
[TBL] [Abstract][Full Text] [Related]
40. Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis.
Loarca L; De Assuncao TM; Jalan-Sakrikar N; Bronk S; Krishnan A; Huang B; Morton L; Trussoni C; Bonilla LM; Krueger E; O'Hara S; Splinter P; Shi G; Pisarello MJL; Gores GJ; Huebert RC; LaRusso NF
Lab Invest; 2017 Nov; 97(11):1385-1396. PubMed ID: 28892096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
